Table 3.
Efficiency of different antibody-conjugated magnetic nanoparticles in separating SK-BR-3 cells.
| MNPs | MFI | Percentage of SK-BR-3 cells |
Percentage of PBMCs |
|||
|---|---|---|---|---|---|---|
| Before separation | After separation | Efficiency (%) | Before separation | After separation | ||
| T17 | 185.56 | 16.60 | 58.90 | 71.80 | 34.10 | 4.50 |
| T19 | 110.19 | 10.80 | 51.90 | 79.20 | 37.30 | 14.10 |
| T25 | 51.75 | 10.40 | 10.90 | 0.00 | 34.80 | 41.60 |
MNPs: magnetic nanoparticles, MFI: mean fluorescence intensity, PBMCs: peripheral blood mononuclear cells. T17: coated with 2.2 mg Herceptin; T19: coated with 0.55 mg; T25: coated with 0.009 mg Herceptin.